Last updated: August 3, 2025
Introduction
South Korean patent KR20130133078, filed by a pharmaceutical innovator, encapsulates the technological advancements in a specific drug formulation or therapeutic method. As with all patents, its scope, claims, and the broader patent landscape are crucial for understanding its strength, potential for infringement, licensing opportunities, and competitive positioning within South Korea’s intellectual property ecosystem.
This analysis offers a comprehensive examination of KR20130133078, dissecting its claims, delineating its scope, and exploring the landscape of related patent rights significant for stakeholders such as pharmaceutical companies, patent attorneys, and R&D strategists.
Patent Overview and Publication Data
Filed: The application publication number KR20130133078 indicates it was filed prior to or around 2013, with publication likely around 2013-2014. Specific filing and priority data would fine-tune the timeline, but generally, patents of this period follow contemporary Korean patent laws emphasizing inventive step, novelty, and industrial applicability.
Scope of the Patent
Scope: The scope defines the boundaries of legal protection, grounded in the claims. For KR20130133078, the scope likely centers on a novel drug formulation, delivery system, or therapeutic method—involving specific active ingredients, excipients, manufacturing processes, or dosing regimens.
The scope's breadth depends heavily on the claim language, especially the independent claims. Broad claims may cover a wide array of formulations or methods, providing extensive protection. Conversely, narrow claims protect specific embodiments, limiting enforcement but increasing defensibility.
Claims Analysis
Independent Claims
A typical independent claim in pharmaceutical patents like KR20130133078 might encompass:
- A specific pharmaceutical composition comprising a defined active ingredient(s) and excipient(s),
- A unique method of preparing the drug,
- A therapeutic method attributable to particular dosing or delivery techniques.
Analyzing claim language reveals key features such as:
- Active Ingredient Choice: Whether the claims specify a particular compound, derivative, or a class of compounds.
- Formulation Details: Considerations like particle size, solubility enhancement, or stability features.
- Delivery Route: Oral, injectable, transdermal, or novel delivery systems.
- Method of Use: For certain indications, e.g., neurodegenerative disorders, cancer, etc.
Dependent Claims
Dependent claims typically narrow the scope, adding features such as:
- Specific dosages,
- Combinations with other agents,
- Stability conditions,
- Manufacturing parameters.
They bolster the robustness of the patent by covering particular embodiments.
Patent Scope Implications
- Legal Breadth: If the independent claims are broad (e.g., "a pharmaceutical composition comprising active ingredient X"), they offer substantial protection but face increased invalidity challenges based on prior art.
- Strategic Positioning: Narrow claims targeting specific formulations or methods can be more defensible but may limit future patenting avenues.
- Potential For Infringement: The scope determines what competitors must avoid to evade infringement. Broad claims might pose risks for overlapping product development.
Patent Landscape Context
Prior Art and Novelty
- Prior art covers earlier patents, publications, or disclosures relevant to the claims.
- For KR20130133078, novelty hinges on specific inventive features—perhaps a new solubility enhancer or a novel delivery method not previously disclosed.
- Searching for core compounds, formulations, or methods reveals whether the patent distinguishes itself clearly.
Overlap with International Patents
- Many pharmaceutical patents obtain global counterparts (e.g., US, EP, CN patents). Cross-referencing these provides insights into patent family prosecution strategies.
- The patent landscape includes similar patents from competitors targeting the same indication or mechanism.
Freedom-to-Operate (FTO)
- The scope of KR20130133078 contributes to an FTO analysis. If broad, it may infringe or be challenged by other patents, especially those filed in Korea or abroad.
- Analyzing non-overlapping claims in competitor patents informs licensing or design-around strategies.
Patent Family and Citing Patents
- The patent family includes related applications filing earlier priority or family members in other jurisdictions.
- Citing patents reveal technological evolution and potential overlapping claims.
Key Features Influencing Patent Landscape
- Innovation Level: How novel and inventive are the fundamental aspects? Highly innovative formulations or delivery routes tend to face fewer challenges.
- Scope Breadth: Broader claims secure wider rights but are more susceptible to invalidity or challenge.
- Claim Dependence & Specificity: Highly dependent claims reinforce specific embodiments, while independent claims set patent boundaries.
Legal and Commercial Positioning
KR20130133078’s enforceability depends on its claim defensibility and the tightness of prior art search. Its position relative to competing patents affects licensing negotiations, collaboration, and market exclusivity.
Conclusion
KR20130133078 embodies a strategic patent, with its scope and claims carefully crafted around novel pharmaceutical compositions or methods relevant to its intended therapeutic area. Its strength lies in its claim specificity balanced against its strategic breadth, influencing its role within South Korea’s pharmaceutical patent landscape.
Key Takeaways
- Scope Optimization: Broad independent claims maximize coverage but require robust novelty and inventive step support.
- Claim Drafting: Detailed dependent claims reinforce core embodiments and provide fallback positions during legal challenges.
- Landscape Awareness: Patent triangulation with global counterparts is vital to assess infringement risks and licensing potential.
- Product Development: Understanding the patent’s scope guides R&D to innovate around the claims or to design non-infringing alternatives.
- Legal Vigilance: Continuous monitoring of related patents ensures ongoing freedom to operate within the evolving landscape.
FAQs
Q1: How does the scope of KR20130133078 affect infringement risk for new drug candidates?
A: Broad claims increase infringement risk if competing products share any feature within the claim language. Narrow claims limit this risk but may provide less comprehensive protection.
Q2: Can this patent be challenged based on prior art?
A: Yes, if prior art disclosures encompass the key features of the claims, challengers can file invalidity or non-infringement actions, especially against broad claims.
Q3: How does filing in Korea compare to international patent strategies?
A: Filing in Korea provides exclusive rights within South Korea, essential for local market access. Considering PCT or direct filings in other jurisdictions broadens market protection.
Q4: What is the importance of dependent claims in patent robustness?
A: Dependent claims narrow the scope, covering specific embodiments, thus strengthening the patent’s defensibility against invalidation.
Q5: How might competitors circumvent KR20130133078?
A: By designing formulations or methods that avoid the specific elements claimed, particularly if claims are narrow and specific. Alternatively, developing different active ingredients or delivery systems may bypass the patent.
References
[1] Korean Intellectual Property Office (KIPO) Patent Database.
[2] WIPO Patentscope.
[3] World Patent Index.
[4] Relevant judicial decisions and legal commentaries on patent validity and infringement.
Note: For detailed claim language, full patent specification, and legal status, consulting the official KR patent document is advised.
